Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide-brimonidine prophylaxis for IOP elevation after anti-VEGF injections
NCT04523844Completed
- Sponsor
- Elpis General Hospital
- Start
- May 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of brinzolamide + brimonidine in ocular hypertension (2 arms), sponsored by Elpis General Hospital. Primary endpoint: Intraocular Pressure at 1 minute post-injection. Started May 2020; status: completed.
02
Drugs
brinzolamide + brimonidine
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT04523844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523844.